Indeed, we found that pre-lymphodepletion serum collected from DLBCL patients modulated the immunoregulatory activity of macrophages so that serum from non-responsive (NR) patients enhanced the immunoregulatory capacity of macrophages, suppressing expansion of human CD19 CAR T cells to levels comparable to imMac. Here, CD19 is linked to diffuse large B-cell lymphoma.